
SOLS is a software platform and mobile application that enables users to design and purchase customized orthotics for their feet. To date, the company has launched two products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct to consumer custom insoles. SOLS is now leveraging its patented footwear customization software to attack the footwear industry's biggest problem, shoe size-related returns. Founded in 2013, SOLS uses state of the art computer vision and machine learning to improve the fit and function of footwear. The company is backed by blue-chip investors like Founders Fund, Lux Capital, and Tenaya Capital and located in New York City.

SOLS is a software platform and mobile application that enables users to design and purchase customized orthotics for their feet. To date, the company has launched two products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct to consumer custom insoles. SOLS is now leveraging its patented footwear customization software to attack the footwear industry's biggest problem, shoe size-related returns. Founded in 2013, SOLS uses state of the art computer vision and machine learning to improve the fit and function of footwear. The company is backed by blue-chip investors like Founders Fund, Lux Capital, and Tenaya Capital and located in New York City.
What they do: Software and mobile platform to design and purchase custom 3D‑printed foot orthotics and consumer insoles
Founded / HQ: 2013; New York, New York
Products: SOLSRx (medical 3D‑printed orthotics), ExoSOLS / SOLS Flex (direct‑to‑consumer insoles)
Tech: Computer vision and machine learning for foot scanning and fit
Funding (reported): $23,700,000 total reported funding (last reported 2016-02-17)
Footwear fit, orthotics, and shoe size–related returns
2013
Medical devices; Consumer footwear/insoles; Software
1750000
Seed round closed Dec 2013 (announced Jan 2014)
6400000
11100000
Round announced Feb 27, 2015; participation reported from Tenaya Capital, Founders Fund and others
“Backed by venture investors including Lux Capital, Founders Fund, RRE, Rothenberg Ventures, Felicis Ventures, Grape Arbor VC, Tenaya Capital, and Melo7/Melo7 Tech Partners”